Why are GLP-1 medications so expensive in the United States compared to elsewhere?
GLP-1 medications are significantly more expensive in the United States largely due to pricing dynamics and limited competition.
In a recent conversation about menopause and weight gain, Dr. Rocio Salas-Whalen explained that these medications cost about one third as much in other parts of the world, including Europe, Latin America, and the Middle East. In the US, there is currently a market dominated by two major pharmaceutical companies, which limits competition and helps keep prices high. As more companies develop similar medications, increased competition may help bring prices down.
You can watch the discussion on cost and accessibility Menopause & Weight Gain | Dr. Rocio Salas-Whalen - Cost and Accessibility of Weight Loss Drugs
How Alloy helps with affordability
Here at Alloy, we focus on making weight care more accessible:
Zepbound® starting at $349 per month
Wegovy® starting at $499 per month
Compounded liraglutide starting at $80 per month
During past medication shortages, the FDA allowed compounding pharmacies to help expand access. Compounded options can be more affordable, and at Alloy we work only with FDA regulated compounding pharmacies that follow strict safety and quality standards. You can read more about that What Is Compounded Liraglutide for Weight Loss? If you want to explore options and see what you may qualify for, you can learn more about our Weight Care Program here
This answer was created using the following resources: